Halozyme Therapeutics (HALO) Debt Ratio (2012 - 2026)
Halozyme Therapeutics (HALO) posted quarterly Debt Ratio of 0.8 for Q1 2026, up 16.92% year-over-year from 0.69 in Q1 2025, and down 5.43% quarter-over-quarter from 0.85 in Q4 2025.
Halozyme Therapeutics (HALO) Debt Ratio (2012 - 2026) Analysis & Trends
Halozyme Therapeutics (HALO) has reported Debt Ratio for 15 consecutive years, with 0.8 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio rose 16.92% year-over-year to 0.8; the TTM figure through Mar 2026 stood at 0.8 (up 16.92% YoY), while the FY2025 annual figure was 0.85, up 16.27% from the prior year.
- Debt Ratio declined to 0.8 in Q1 2026 per HALO's latest filing, from 0.85 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.88 in Q1 2023 and bottomed at 0.68 in Q3 2025.
- Historically, Debt Ratio has averaged 0.78 across 5 years, with a median of 0.79 in 2023.
- Annual changes were most pronounced in 2022 — Debt Ratio decreased 17.96% — and 2023, when it increased 18.12%.
- Halozyme Therapeutics' Debt Ratio stood at 0.83 in 2022, then increased by 4.83% to 0.86 in 2023, then decreased by 15.64% to 0.73 in 2024, then rose by 16.27% to 0.85 in 2025, then retreated by 5.43% to 0.8 in 2026.
- Business Quant data shows HALO's Debt Ratio at 0.8 in Q1 2026, 0.85 in Q4 2025, and 0.68 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Halozyme Therapeutics | 11.25 Bn | 11.02 Bn | 401.83 Mn | 0.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.83 |
| Mar 31, 2026 | 0.80 |
| Dec 31, 2025 | 0.85 |
| Sep 30, 2025 | 0.68 |
| Jun 30, 2025 | 0.73 |
| Mar 31, 2025 | 0.69 |
| Dec 31, 2024 | 0.73 |
| Sep 30, 2024 | 0.71 |
| Jun 30, 2024 | 0.76 |
| Mar 31, 2024 | 0.82 |
| Dec 31, 2023 | 0.86 |
| Sep 30, 2023 | 0.79 |
| Jun 30, 2023 | 0.83 |
| Mar 31, 2023 | 0.88 |
| Dec 31, 2022 | 0.83 |
| Sep 30, 2022 | 0.81 |
| Jun 30, 2022 | 0.70 |
| Mar 31, 2022 | 0.76 |
| Dec 31, 2021 | 0.79 |
| Sep 30, 2021 | 0.74 |